Unknown × Drug-Related Side Effects and Adverse Reactions × Clear all Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
Unknown
1,000 enrolled
Applying Mobile Healthcare Education to Improve Cutaneous Self-care Capability
Phase NA Unknown
110 enrolled
ACTME
Phase 1/2 Unknown
34 enrolled
ASF-BC
Phase 3 Unknown
100 enrolled
NEOCARDIO
Unknown
5,000 enrolled
SeliGIST
Phase 1/2 Unknown
30 enrolled
Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy
Phase NA Unknown
128 enrolled
Possible Differences in HCC Course Depending on DAA Treatment
Unknown
100 enrolled
Rheumatologic Adverse Events and Cancer Immunotherapy
Phase NA Unknown
400 enrolled
Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas
Phase 2 Unknown
20 enrolled
The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole
Unknown
34 enrolled
MAPAC
Phase 2 Unknown
60 enrolled
Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients
Unknown
2,200 enrolled
Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients
Unknown
2,200 enrolled
Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma (GTN) Patients With Score of 5-6
Phase 2/3 Unknown
300 enrolled
AFERBIO
Phase NA Unknown
104 enrolled
Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy
Phase 2 Unknown
30 enrolled
High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs
Phase 2 Unknown
20 enrolled
HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis
Phase 2 Unknown
40 enrolled
Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients
Phase 2 Unknown
86 enrolled
Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia
Phase 2 Unknown
38 enrolled
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
Phase 1/2 Unknown
46 enrolled
Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer
Phase 2 Unknown
20 enrolled
Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
Phase 1/2 Unknown
Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Unknown
TACEHBV
Phase 4 Unknown
80 enrolled